A prospective, randomized, open-label, controlled study evaluating the efficacy and safety of fluvastatin on telaprevir-based combination therapy for patients with chronic hepatitis C genotype 1b infection.
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2015
At a glance
- Drugs Fluvastatin (Primary) ; Peginterferon alfa; Ribavirin; Telaprevir
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2015 New trial record